Campos-Outcalt D, Aickin M
Department of Family and Community Medicine, Maricopa Health System, Phoenix, Arizona, USA.
Am J Prev Med. 1997 Mar-Apr;13(2):98-103.
Our objective was to investigate the relationship of vaccine or toxoid licensure with the incidence of the target disease in the United States.
We used a historical correlational study design with outcome measures of the national incidence and elimination rate of polio, pertussis, diphtheria, and measles as well as the New York City incidence and elimination rate of mumps, rubella, and tetanus.
The licensure of pertussis, measles, polio, mumps, and rubella vaccine was followed by an increase in the elimination rate of disease. The elimination rates of diphtheria and tetanus apparently worsened following the licensure of the respective toxoids.
Historical data provide evidence of proof of efficacy of mass immunization for measles, polio, rubella, mumps, and pertussis, but not for diphtheria or tetanus.
我们的目的是研究疫苗或类毒素许可与美国目标疾病发病率之间的关系。
我们采用历史相关性研究设计,以脊髓灰质炎、百日咳、白喉和麻疹的全国发病率及消除率,以及纽约市腮腺炎、风疹和破伤风的发病率及消除率作为结果指标。
百日咳、麻疹、脊髓灰质炎、腮腺炎和风疹疫苗获得许可后,疾病消除率有所上升。白喉和破伤风类毒素获得许可后,其消除率显然恶化。
历史数据为麻疹、脊髓灰质炎、风疹、腮腺炎和百日咳大规模免疫的有效性提供了证据,但对白喉或破伤风则没有。